Description
This presentation will introduce new medications, discuss their pharmacologic properties, and dive into clinical applications useful for the Dentist Anesthesiologist.
Attendees will come away with an introduction to the following novel medications:
- BYFAVO® (Remimzolam): a new sedative with an ultra-short half-life that will improve safety of moderate sedation in dentistry.
- CLEVIPREX® (Clevidipine): A fast-acting, ultra-short half-life dihydropyridine calcium channel blocker used to rapidly reduce systolic blood pressure within two minutes of initial dosing.
- DSUVIA® (Sublingual Sufenanil): an enteral form of sufentanil FDA approved for management of moderate to severe pain.
- EXPAREL® (Liposomal Bupivicaine): Bupivicaine encapsulated in multivesicular liposomes injected locally for long lasting post-surgical pain management.
- AKYNZEO® (Netupitant/Palonosetron): An anti-nausea medication for treatment of chemotherapy induced nausea and vomiting utilizing both a NK-1 receptor antagonist and a 5-HT3 receptor antagonist in one pill or injectable.